SANDU PHARMACEUTICALS LTD. Share Price
SANDU PHARMACEUTICALS LTD. Share Price Today
As of 5 Jul 2026, SANDU PHARMACEUTICALS LTD. share price is ₹41.60. The stock opened at ₹41.60, compared to its previous close of ₹41.35. During today's trading session, SANDU PHARMACEUTICALS LTD. share price moved in the range of ₹41.00 to ₹41.60, with an average price of ₹41.30 for the day. Looking at its last 52-week, the stock has touched a low of ₹30.00 and a high of ₹58.28.
SANDU PHARMACEUTICALS LTD. Returns Calculator
SANDU PHARMACEUTICALS LTD. Shareholder Returns
SANDU PHARMACEUTICALS LTD. Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
SANDU PHARMACEUTICALS LTD. Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Revenue | ₹67.19 | ₹67.28 | ₹65.35 |
| Other Income | ₹0.17 | ₹0.42 | ₹0.33 |
| Total Revenue | ₹67.36 | ₹67.70 | ₹65.68 |
| Total Expenses | ₹65.20 | ₹65.63 | ₹63.46 |
| Profit Before Tax | ₹2.16 | ₹2.07 | ₹2.22 |
| Tax | ₹0.61 | ₹0.61 | ₹0.70 |
| Profit After Tax | ₹1.55 | ₹1.46 | ₹1.52 |
| EPS - Basic | ₹1.60 | ₹1.51 | ₹1.62 |
| EPS - Diluted | ₹1.60 | ₹1.51 | ₹1.62 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Profit before tax | ₹2.16 | ₹2.07 | ₹2.22 |
| Income before WC changes | ₹2.86 | ₹2.48 | ₹2.69 |
| Change in Assets | -₹2.13 | ₹2.61 | -₹3.99 |
| Change in Liabilities | ₹0.80 | -₹3.83 | ₹2.21 |
| Change in WC | -₹1.32 | -₹1.22 | -₹1.77 |
| Cash flow from Operations | ₹0.95 | ₹0.76 | ₹0.22 |
| Cash flow from Investing | -₹0.19 | -₹1.31 | ₹0.54 |
| Cash flow from Financing | -₹0.46 | -₹0.72 | ₹0.58 |
| Total Cash Flow | ₹0.30 | -₹1.27 | ₹1.34 |
| Cash (Start of the year) | ₹1.00 | ₹2.28 | ₹0.94 |
| Cash (End of the year) | ₹1.30 | ₹1.00 | ₹2.28 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Non-Current Assets | ₹29.42 | ₹30.11 | ₹28.62 |
| Current Assets | ₹26.30 | ₹22.30 | ₹25.55 |
| Total Assets | ₹55.72 | ₹52.41 | ₹54.17 |
| Current Liabilities | ₹12.09 | ₹10.64 | ₹13.88 |
| Net Current Asset | ₹14.21 | ₹11.66 | ₹11.66 |
| Non-Current Liabilities | ₹1.62 | ₹1.18 | ₹1.04 |
| Equity Capital | ₹42.02 | ₹40.59 | ₹39.24 |
| Total Equity & Liabilities | ₹55.72 | ₹52.41 | ₹54.17 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹67.19 | ₹67.28 | ₹65.35 | ₹65.50 |
| Other Income | ₹0.17 | ₹0.42 | ₹0.33 | ₹0.08 |
| Total Revenue | ₹67.36 | ₹67.70 | ₹65.68 | ₹65.58 |
| Total Expenses | ₹65.20 | ₹65.63 | ₹63.46 | ₹63.27 |
| Profit Before Tax | ₹2.16 | ₹2.07 | ₹2.22 | ₹2.32 |
| Tax | ₹0.61 | ₹0.61 | ₹0.70 | ₹0.73 |
| Profit After Tax | ₹1.55 | ₹1.46 | ₹1.52 | ₹1.59 |
| EPS - Basic | ₹1.60 | ₹1.51 | ₹1.62 | ₹1.99 |
| EPS - Diluted | ₹1.60 | ₹1.51 | ₹1.62 | ₹1.87 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹2.16 | ₹2.07 | ₹2.22 | ₹2.32 |
| Income before WC changes | ₹2.86 | ₹2.48 | ₹2.70 | ₹2.95 |
| Change in Assets | -₹2.13 | ₹2.61 | -₹3.99 | ₹0.23 |
| Change in Liabilities | ₹0.80 | -₹3.83 | ₹2.21 | -₹1.36 |
| Change in WC | -₹1.32 | -₹1.22 | -₹1.78 | -₹1.13 |
| Cash flow from Operations | ₹0.95 | ₹0.76 | ₹0.22 | ₹0.95 |
| Cash flow from Investing | -₹0.18 | -₹1.31 | ₹0.53 | -₹5.47 |
| Cash flow from Financing | -₹0.46 | -₹0.72 | ₹0.58 | ₹0.93 |
| Total Cash Flow | ₹0.31 | -₹1.27 | ₹1.33 | -₹3.59 |
| Cash (Start of the year) | ₹1.00 | ₹2.27 | ₹0.94 | ₹4.53 |
| Cash (End of the year) | ₹1.30 | ₹1.00 | ₹2.27 | ₹0.94 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹29.42 | ₹30.12 | ₹28.63 | ₹25.64 |
| Current Assets | ₹26.30 | ₹22.30 | ₹25.54 | ₹23.65 |
| Total Assets | ₹55.72 | ₹52.42 | ₹54.17 | ₹49.28 |
| Current Liabilities | ₹12.09 | ₹10.64 | ₹13.88 | ₹11.87 |
| Net Current Asset | ₹14.21 | ₹11.66 | ₹11.66 | ₹11.77 |
| Non-Current Liabilities | ₹1.62 | ₹1.18 | ₹1.04 | ₹0.94 |
| Equity Capital | ₹42.02 | ₹40.60 | ₹39.24 | ₹36.47 |
| Total Equity & Liabilities | ₹55.72 | ₹52.42 | ₹54.17 | ₹49.28 |
About SANDU PHARMACEUTICALS LTD.
Sandu Pharmaceuticals Limited is an India-based company, which is mainly engaged in the business of manufacturing and trading of ayurvedic medicines under the brand name, SANDU. The Company's product category includes digestive health, immunity, muscle and bone health, respiratory health, wellness, and others. Its digestive health products focus on constipation, hyperacidity, indigestion and flatulence, and loose motions, among others. Its wellness products cover female wellness, male wellness and mother and child. Its respiratory health products focus on respiratory health, asthma, and cold and cough. Its ayurveda category includes herbs, panchakarma, dincharya, rutucharya, ahar vihar, arogyadarshika, prakruti and yoga. The Company also offers products, such as an immunity kit and a power herbs range. Its products are manufactured using in-house know-how supplied by Sandu Brothers Private Limited. The Company's products are sold through e-commerce marketplaces.
SANDU PHARMACEUTICALS LTD. Financial Highlights
- Revenue: SANDU PHARMACEUTICALS LTD. reported revenue of ₹67.36 crore in FY25 vs ₹67.70 crore in FY24. It showed a decrease of 0.50% on a yearly basis.
- Operating Profit: SANDU PHARMACEUTICALS LTD. reported an operating profit of ₹2.16 crore in FY25 vs ₹2.07 crore in FY24. It showed an increase of 4.35% on a year-on-year basis.
- Net Profit: SANDU PHARMACEUTICALS LTD. reported a net profit of ₹1.55 crore in FY25 vs ₹1.46 crore in FY24. It showed an increase of 6.16% on a yearly basis.
SANDU PHARMACEUTICALS LTD. Quarterly Result Highlights
- SANDU PHARMACEUTICALS LTD. reported revenue of ₹14.14 crore in Mar 2025, compared with ₹18.39 crore in Dec 2024, representing a decrease of 23.11% on a quarter-on-quarter (QoQ) basis.
- SANDU PHARMACEUTICALS LTD. reported an operating profit of ₹0.34 crore in Mar 2025, compared with ₹0.80 crore in Dec 2024, representing a decrease of 57.50% on a quarter-on-quarter (QoQ) basis.
- SANDU PHARMACEUTICALS LTD. reported a profit of ₹0.33 crore in Mar 2025, compared with ₹0.56 crore in Dec 2024, reflecting a decrease of 41.07% on a QoQ basis.
- The earnings per share (EPS) of SANDU PHARMACEUTICALS LTD. stood at ₹1.60 during Mar 2025.
Similar Stocks
FAQs on SANDU PHARMACEUTICALS LTD. Share Price
What is SANDU PHARMACEUTICALS LTD. share price today?
SANDU PHARMACEUTICALS LTD. share price is ₹41.60 as on 03 Jul, 2026, 15:17 IST.
How has the SANDU PHARMACEUTICALS LTD. share price performed in the past?
In the last 1 year, SANDU PHARMACEUTICALS LTD. delivered a return of -17.10%. The SANDU PHARMACEUTICALS LTD. share price hit a high of ₹58.28 and low of ₹30.00.
How much is the Mutual Fund shareholding in SANDU PHARMACEUTICALS LTD. shares?
The Mutual Fund Shareholding in SANDU PHARMACEUTICALS LTD. was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of SANDU PHARMACEUTICALS LTD. shares ?
The 52-week high and low of SANDU PHARMACEUTICALS LTD. share is ₹58.28 and ₹30.00 as of 03 Jul, 2026.
What is the market cap of SANDU PHARMACEUTICALS LTD.?
The market capitalisation of SANDU PHARMACEUTICALS LTD. is ₹39.95 Crores as on 03 Jul, 2026.
What are the stock symbols of SANDU PHARMACEUTICALS LTD.?
The stock symbol of SANDU PHARMACEUTICALS LTD. is 524703 on the BSE, and the ISIN is INE751D01014.
What was yesterday's closing price for SANDU PHARMACEUTICALS LTD. shares ?
SANDU PHARMACEUTICALS LTD. shares closed yesterday at ₹41.35 on BSE
How to buy SANDU PHARMACEUTICALS LTD. shares?
To buy SANDU PHARMACEUTICALS LTD. shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy SANDU PHARMACEUTICALS LTD. shares on Holidays?
No, shares of SANDU PHARMACEUTICALS LTD. or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell SANDU PHARMACEUTICALS LTD. shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of SANDU PHARMACEUTICALS LTD.?
The PE and PB ratio of SANDU PHARMACEUTICALS LTD. is 30.43 and 1.41 respectively, as on 03 Jul, 2026, 15:17 IST.